M. K. Proteins Past Earnings Performance

Past criteria checks 3/6

M. K. Proteins hat die Erträge mit einer durchschnittlichen jährlichen Rate von 37.1% gesteigert, während die Branche Food die Erträge growing mit 17.7% jährlich steigerte. Die Einnahmen sind declining mit einer durchschnittlichen Rate von 0.5% pro Jahr gestiegen. M. K. Proteins Die Eigenkapitalrendite des Unternehmens beträgt 18.5%, und die Nettomargen liegen bei 3.7%.

Key information

37.1%

Earnings growth rate

37.1%

EPS growth rate

Food Industry Growth17.6%
Revenue growth rate-0.5%
Return on equity18.5%
Net Margin3.7%
Last Earnings Update30 Sep 2023

Recent past performance updates

Weak Statutory Earnings May Not Tell The Whole Story For M. K. Proteins (NSE:MKPL)

Jun 07
Weak Statutory Earnings May Not Tell The Whole Story For M. K. Proteins (NSE:MKPL)

Recent updates

What You Can Learn From M. K. Proteins Limited's (NSE:MKPL) P/EAfter Its 26% Share Price Crash

Mar 22
What You Can Learn From M. K. Proteins Limited's (NSE:MKPL) P/EAfter Its 26% Share Price Crash

Should You Be Adding M. K. Proteins (NSE:MKPL) To Your Watchlist Today?

Feb 09
Should You Be Adding M. K. Proteins (NSE:MKPL) To Your Watchlist Today?

Some Confidence Is Lacking In M. K. Proteins Limited's (NSE:MKPL) P/S

Jan 05
Some Confidence Is Lacking In M. K. Proteins Limited's (NSE:MKPL) P/S

We Think M. K. Proteins (NSE:MKPL) Can Stay On Top Of Its Debt

Jul 20
We Think M. K. Proteins (NSE:MKPL) Can Stay On Top Of Its Debt

We Think M. K. Proteins (NSE:MKPL) Is Taking Some Risk With Its Debt

Sep 23
We Think M. K. Proteins (NSE:MKPL) Is Taking Some Risk With Its Debt

Weak Statutory Earnings May Not Tell The Whole Story For M. K. Proteins (NSE:MKPL)

Jun 07
Weak Statutory Earnings May Not Tell The Whole Story For M. K. Proteins (NSE:MKPL)

Here's Why I Think M. K. Proteins (NSE:MKPL) Is An Interesting Stock

Mar 16
Here's Why I Think M. K. Proteins (NSE:MKPL) Is An Interesting Stock

Does M. K. Proteins (NSE:MKPL) Deserve A Spot On Your Watchlist?

Sep 29
Does M. K. Proteins (NSE:MKPL) Deserve A Spot On Your Watchlist?

Is Now The Time To Put M. K. Proteins (NSE:MKPL) On Your Watchlist?

Mar 16
Is Now The Time To Put M. K. Proteins (NSE:MKPL) On Your Watchlist?

Revenue & Expenses Breakdown
Beta

How M. K. Proteins makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:MKPL Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 232,65298230
31 Mar 233,149106190
30 Sep 222,82287200
30 Jun 222,69194200
31 Mar 222,559102190
31 Dec 212,907114170
30 Sep 213,253127160
30 Jun 213,182115160
31 Mar 213,111104150
31 Dec 202,80075160
30 Sep 202,48846160
30 Jun 202,21632160
31 Mar 201,94418170
31 Dec 191,72317170
30 Sep 191,50216180
30 Jun 191,53516180
31 Mar 191,56816180
31 Mar 181,71714180
31 Mar 171,64510190
31 Mar 161,4487140
31 Mar 151,2328110
31 Mar 141,217580

Qualität der Erträge: MKPL hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: MKPLDie aktuellen Gewinnspannen (3.7%) sind höher als im letzten Jahr (3.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Ergebnisentwicklung: MKPLIn den letzten 5 Jahren sind die Einnahmen von 37.1% pro Jahr erheblich gestiegen.

Beschleunigtes Wachstum: MKPLDas Gewinnwachstum des Unternehmens im letzten Jahr (13.3%) liegt unter seinem 5-Jahres-Durchschnitt (37.1% pro Jahr).

Erträge im Vergleich zur Industrie: MKPL Das Gewinnwachstum im vergangenen Jahr (13.3%) übertraf nicht die Entwicklung der Branche Food 19.8% .


Return on Equity

Hohe Eigenkapitalrendite: MKPLDie Eigenkapitalrendite des Unternehmens (18.5%) wird als niedrig angesehen.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.